Based on the definition of Sepsis-3, a combined biomarker approach that includes PCT, IL-6, pentraxin-3 and lactate showed promising results in predicting 28-day all-cause mortality in patients diagnosed with sepsis or septic shock. This evidence concerns the gene CALCA and Sepsis.